Company Overview and News
NE PAS DISTRIBUER À DES SERVICES DE FIL DE PRESSE AUX ÉTATS-UNIS NI DIFFUSER, PUBLIER OU DISTRIBUER DIRECTEMENT OU INDIRECTEMENT, EN TOTALITÉ OU EN PARTIE, AUX ÉTATS-UNIS
Stocks plunged on the Tokyo Stock Exchange on Wednesday, bruised by the yen’s advance against the dollar.
May 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Wednesday:
SoftBank Group said on Wednesday it is selling its roughly 20 percent stake in Indian e-commerce firm Flipkart to Walmart.
TOKYO (Reuters) - SoftBank Group Corp (9984.T) said on Wednesday it is selling its roughly 20 percent stake in Indian e-commerce firm Flipkart [IPO-FLPK.N] to Walmart Inc (WMT.N).
(Reuters) - Canada’s Nemaska Lithium (NMX.TO) said on Tuesday it had secured funding of up to C$402 million ($314 million) from investors, which it plans to use to build a mine and processing plant to produce lithium, the key ingredient for rechargeable batteries.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN THE UNITED STATES
TOKYO (Reuters) - Uber Technologies plans to launch its first taxi-hailing pilot service in Japan that will connect passengers to other taxi providers, as it seeks to expand in the country where the U.S. firm has been blocked from setting up its own fleet of drivers.
Cyber security researchers have found a new security flaw that affects a broad swath of modern computing chips and is related to the Spectre and Meltdown chip flaws that emerged in January.
(Reuters) - Cyber security researchers have found a new security flaw that affects a broad swath of modern computing chips and is related to the Spectre and Meltdown chip flaws that emerged in January.
NEW YORK (Reuters) - Kabbage Inc, a U.S. online lender for small businesses, plans to launch payment processing services by year-end, President Kathryn Petralia said on Monday, helping it to diversify and compete more directly with industry leaders PayPal Holdings Inc and Square Inc.
Alphabet, the holding company of tech giant Google is yet to make a decision on acquiring a minority stake in Flipkart, according to a Business Standard report.
Bengaluru: Walmart Inc. has sought the approval of India’s anti-trust regulator for its $16-billion acquisition of Flipkart, according to a regulatory filing.
WASHINGTON/BOSTON – SoftBank Group Corp. Chairman Masayoshi Son has battled for years to merge T-Mobile U.S. Inc. with his Sprint Corp. Now that he finally has a deal, he risks having his hands tied by a secretive U.S. government panel.
Bengaluru/New Delhi: Sachin Bansal’s fate at Flipkart was sealed in Bentonville, Arkansas, in late April. Sachin Bansal, co-founder and then chairman of Flipkart, along with Lee Fixel and other representatives of the company were hunkered down in Arkansas, home of retail giant Walmart Inc. They were in the last stage of negotiations to sell a majority stake in Flipkart Pvt. Ltd to Walmart.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...